• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHU Yujie,ZHOU Yaochuan,NI Jingyang,LI Tingting.Research Progress on Sphingolipid Metabolism Enzymes in Liver Diseases[J].Journal Of Pharmaceutical Research,2025,44(7):690-695,702[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2217times   Download 741次 QR Code for this article
Scan with your phone!
鞘脂代谢相关酶在肝脏疾病中的研究进展
朱雨洁,周耀传,倪菁阳,李婷婷
Font:Larger+|Default|Smaller-
(中国药科大学药学院,江苏 南京 210009)
摘要:
鞘脂(sphingolipids)对维持细胞膜的完整性和作为活性脂质信号分子的功能是必不可少的,其各种代谢物积极维持肝脏生理稳态。而在病理状态下,鞘脂代谢物以及调控酶稳态紊乱,通过多种方式调控肝脏疾病的发生与进展。大量研究表明,靶向鞘脂代谢核心神经酰胺及其合成代谢酶是治疗急性和慢性肝脏疾病的有效策略之一。本文综述了几种鞘脂代谢酶在肝脏疾病中的作用,并对相关靶向治疗研究进展进行简介,旨在为肝脏疾病发病机制的阐明和临床治疗手段的开发提供新的思路与参考。
关键词:  神经酰胺  肝脏疾病  丝氨酸棕榈酰基转移酶  神经酰胺酶  鞘氨醇激酶  中性鞘磷脂酶2
DOI:10.13506/j.cnki.jpr.2025.07.010
基金项目:国家自然科学基金项目(No.81503150);中央高校基本科研业务专项资金项目(No.2632019ZD05)
Research Progress on Sphingolipid Metabolism Enzymes in Liver Diseases
ZHU Yujie,ZHOU Yaochuan,NI Jingyang,LI Tingting
(School of Pharmacy, China Pharmaceutical University,Nanjing 210009,China)
Abstract:
Sphingolipids are essential for maintaining the integrity of cell membranes and functioning as bioactive lipid signaling molecules, and their various metabolites actively sustain hepatic physiological homeostasis. However, under pathological conditions, the homeostasis of sphingolipid metabolites and regulatory enzymes is disrupted, leading to dysregulation that modulates the occurrence and progression of liver diseases through multiple mechanisms. Extensive studies have shown that targeting ceramide, a central sphingolipid metabolite, and its synthetic metabolic enzymes is one of the effective strategies for treating both acute and chronic liver diseases. This review summarized the roles of several sphingolipid metabolic enzymes in liver diseases and provided an overview of the progress in related targeted therapies, aiming to offer new insights and references for elucidating the pathogenesis of liver diseases and developing clinical therapeutic approaches.
Key words:  Ceramide  Liver diseases  Serine-palmitoyl transferase  Ceramidase  Sphingosine kinase  Neutral sphingomyelinase 2
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.